Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$12.95 USD
-0.11 (-0.84%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $12.96 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/25/2024
Time: BMO |
3/2024 | $-1.63 | -6.44% |
Earnings Summary
For their last quarter, Sage Therapeutics (SAGE) reported earnings of -$0.55 per share, beating the Zacks Consensus Estimate of $-1.18 per share. This reflects a positive earnings surprise of 53.39%. Look out for SAGE's next earnings release on April 25, 2024. For the next earning release, we expect the company to report earnings of -$1.63 per share, reflecting a year-over-year increase of 33.74%.
Earnings History
Price & Consensus
Zacks News for SAGE
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
SAGE: What are Zacks experts saying now?
Zacks Private Portfolio Services